Preclinical Validation of First in Man Endovascular Brain Machine Interface Device

Grant number: 1138110 | Funding period: 2018 - 2020

Completed

Abstract

The stentrode technology has been given significant public attention, following publication in the fourth highest impact factor journal 'Nature Biotechnology' and a public statement of endorsement by the President of the United States in 2016. The program now seeks to conduct a preclinical validation program to satisfy the FDA in its requirements to provide Investigational Device Exemption (IDE).

Related publications (1)

Motor neuroprosthesis implanted with neurointerventional surgery improves capacity for activities of daily living tasks in severe paralysis: First in-human experience

TJ Oxley, PE Yoo, GS Rind, SM Ronayne, CMS Lee, C Bird, V Hampshire, RP Sharma, A Morokoff, DL Williams, C MacIsaac, ME Howard, L Irving, I Vrljic, C Williams, SE John, F Weissenborn, M Dazenko, AH Balabanski, D Friedenberg

2021-02-01

Background Implantable brain-computer interfaces (BCIs), functioning as motor neuroprostheses, have the potential to restore volun..

University of Melbourne Researchers

Thomas Oxley

Nicholas Opie